Celator Pharmaceuticals Receives Orphan Drug Designation For Anticancer Agent CPX-351
Medical News Today
Sat, 09/6/08 - 10:34 am
Amrubicin Receives FDA Fast Track Designation For The Treatment Of Small Cell Lung Cancer After First-Line Chemotherapy
Medical News Today
Sat, 09/6/08 - 10:33 am
FDA posts list of potential problem drugs
Forbes
Sat, 09/6/08 - 10:31 am
Lilly Zyprexa Group Buyers Win Class Action Status
Bloomberg
Fri, 09/5/08 - 11:48 am
Martek Biosciences stock jumps on strong 3Q profit
Bizjournals.com
Fri, 09/5/08 - 11:47 am
FDA orders stronger warnings for 4 arthritis drugs
Yahoo/AP
Fri, 09/5/08 - 10:11 am
Health Winners & Losers: Abbott
Yahoo/TheStreet.com
Fri, 09/5/08 - 09:08 am
Pfizer Awaits Fablyn Probe
Forbes
Fri, 09/5/08 - 09:07 am
Elan and Biogen initiate first Phase I/II myeloma trial
Pharmaceutical Business Review
Fri, 09/5/08 - 09:04 am
Outsourcing the Drug Industry
Yahoo/Businessweek
Fri, 09/5/08 - 09:03 am
Five Presentations from the Recent Biotech Investment Conference
Seeking Alpha
Fri, 09/5/08 - 09:01 am
Chinese Scientists Build Big Pharma Back Home
Businessweek
Fri, 09/5/08 - 08:59 am
Probe of Vytorin data widens on Capitol Hill
Star Ledger, NJ
Fri, 09/5/08 - 08:56 am
Big pharma keen on partnering with academia
Pharmaceutical Business Review
Fri, 09/5/08 - 08:54 am
Biovail seeks OK for generic cholesterol pill
Yahoo/AP
Fri, 09/5/08 - 08:53 am
At The End Of The Day: Dendreon
CNBC
Thu, 09/4/08 - 05:17 pm
Zimmer Holdings says it has reached deal to acquire Abbott Spine
Yahoo/AP
Thu, 09/4/08 - 05:16 pm
Biotech Is in a Funk
Yahoo/Real Money/TheStreet.com
Thu, 09/4/08 - 02:57 pm
Neurocrine Bio a Buy Under $5
Yahoo/Zacks.com
Thu, 09/4/08 - 02:56 pm
Celgene's Success Story
CNBC
Thu, 09/4/08 - 02:50 pm

Pages